Brief: Grand Pharmaceutical Says Acquisition Of Stake In Chongqing Duoputai Pharmaceutical Technology
15/01/2024 10:35
Jan 15 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF
EQUITY
INTEREST IN CHONGQING DUOPUTAI PHARMACEUTICAL TECHNOLOGY CO.,
LTD
* UNIT AGREED TO ACQUIRE FURTHER 63% STAKE IN CHONGQING
DUOPUTAI
PHARMACEUTICAL TECHNOLOGY
* DEAL FOR RMB442.26 MILLION
* UPON COMPLETION OF SECOND ACQUISITION DEAL, UNIT WILL HOLD
90%
STAKE IN CHONGQING DUOPUTAI PHARMACEUTICAL TECHNOLOGY
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement